tiprankstipranks
Soligenix Inc (SNGX)
NASDAQ:SNGX
US Market
SNGX
Soligenix
RESEARCH TOOLSreports
Want to see SNGX full AI Analyst Report?

Soligenix (SNGX) Stock News & Sentiment

761 Followers
Soligenix Halts FLASH2 Trial, Explores Strategic Alternatives
Premium
Company Announcements
Soligenix Halts FLASH2 Trial, Explores Strategic Alternatives
7d ago
8K
SNGX
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 
Premium
TipRanks Newswire
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 
14d ago
SNGX
Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status
Premium
TipRanks Newswire
Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status
15d ago
SNGX
Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results
Premium
TipRanks Newswire
Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results
18d ago
SNGX
Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy 
Premium
TipRanks Newswire
Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy 
1M ago
SNGX
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
Premium
TipRanks Newswire
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
1M ago
SNGX
SNGX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SNGX Earnings this Week: How Will it Perform?
1M ago
SNGX
More SNGX News >

SNGX News on the Web

Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results
TipRanks News
Neutral
Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy
TipRanks News
Bullish
Soligenix’s HyBryte shows efficacy in T-cell lymphoma published trial
TipRanks News
Neutral
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
SNGX Earnings this Week: How Will it Perform?
TipRanks News
Neutral
Soligenix (NASDAQ: SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behçet Disease
TipRanks News
Bullish
Soligenix’s SGX945 granted European Orphan Drug Designation in Behcet’s Disease
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SNGX
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNGX’s Media Buzz Sentiment?
Currently, no data Available
What is SNGX’s weekly average amount of articles?
Currently, no data Available
What is SNGX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week